Aegerion
Pharmaceuticals Inc. (Nasdaq: AEGR) narrowed losses for the third quarter
to 20 cents per share compared with 43 cents per share last year but revenue fell short of expectations and the company lowered its full
year revenue outlook. The stock price plummeted $14.16 to $20.05.
Aegerion Pharmaceuticals falls short
October 31, 2014 at 14:30 PM EDT